PATENT CLAIM ANALYSIS

Application Number: 15747843
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "265100"]

Abstract:
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 11):
A compound according to  claim 1  or a pharmaceutically acceptable salt thereof for use in the treatment of diseases or conditions for which a TGF\u00dfR antagonist is indicated.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.43333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15755636', '14977709', '15612030', '13534127', '15088211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7983893326977367
- 35 USC 102 Novelty (BERT): 0.5218199333496039
- Combined Prediction Score: 0.7707323927629235
- Mean Citation Score: 307.65078
- Max Citation Score: 335.2428
- Similarity Product: 289.10985233445166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test